Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2015

Open Access 01-12-2015 | Research article

Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients

Authors: Stanley IR Okoduwa, Ismaila A Umar, Sani Ibrahim, Fatima Bello, Nathan Habila

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2015

Login to get access

Abstract

Background

The association between hypertension and diabetes has been linked to increased oxidative stress with age. This study was to examine the level of age-dependent alterations in antioxidant defense system between patients having hypertension and/or type-2 diabetes.

Methods

The study was conducted at the Ahmadu Bello University Teaching Hospital, Zaria-Nigeria, using 200 Subjects recruited from the cardiology, endocrinology and outpatient clinics. They were divided into four groups of 50 subjects each, namely: Diabetic group (DG), hypertensive (HG) and hypertensive-diabetic group (HDG) as cases. The control group (CG) was non-diabetic normotensive subjects. They were all stratified into six age-ranges namely 20–29, 30–39, 40–49, 50–59, 60–69, 70–79 years. Oxidative stress markers (lipid peroxidation, antioxidant vitamins and elements, enzymatic and non-enzymatic antioxidant) were measured in the blood sample collected from all subjects in each age group within the study groups.

Results

The results in the DG, HG and HDG, showed that the percentage decrease in enzymatic antioxidants and antioxidant vitamins with age were significantly (P < 0.05) higher than 10.8% and 20.0% respectively when compared to the CG, whereas, the level of decrease in serum Selenium at same age range was significantly higher than 52.8%. The level of lipid peroxidation in the cases was observed to be significantly (P < 0.05) higher than 89.9% when compared to the mean reference values (2.94 ± 0.05 nmol/ml) of the CG at same age range. Also, the decrease levels of endogenous antioxidants were observed to be directly related to aging.

Conclusion

The result obtained demonstrates the percentage age-dependent alteration in oxidative stress markers. The percentage decrease in the antioxidant levels during aging could be an explanation to the possible link, underlying the complication of type-2 diabetes and hypertension in this locale. Hence, antioxidants supplements may be useful in the management of the diseases during aging.
Literature
1.
go back to reference Cheng Y, Malik U, Chang S. The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy. Int J Diabetes Dev Ctries. 2013;33 Suppl 2:128.CrossRef Cheng Y, Malik U, Chang S. The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy. Int J Diabetes Dev Ctries. 2013;33 Suppl 2:128.CrossRef
2.
go back to reference Kide S, Rangari A, Shiral R, Mane N, Yadav P, Ambulkar K, et al. Knowledge and awareness of diabetes amongst diabetes patients in Wardha region. Int J Diabetes Dev Ctries. 2014. doi:10.1007/s13410-013-0178-3. Kide S, Rangari A, Shiral R, Mane N, Yadav P, Ambulkar K, et al. Knowledge and awareness of diabetes amongst diabetes patients in Wardha region. Int J Diabetes Dev Ctries. 2014. doi:10.1007/s13410-013-0178-3.
3.
go back to reference Singh DK. Diabetic nephropathy: associated risk factors in renal deterioration. Int J Diabetes Dev Ctries. 2012;32 Suppl 3:113–5.CrossRef Singh DK. Diabetic nephropathy: associated risk factors in renal deterioration. Int J Diabetes Dev Ctries. 2012;32 Suppl 3:113–5.CrossRef
4.
go back to reference Pasupathi P, Bakthvathsalam G, Saravanan G, Latha R. Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus. J Appl Sci Res. 2009;5 Suppl 7:770–5. Pasupathi P, Bakthvathsalam G, Saravanan G, Latha R. Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus. J Appl Sci Res. 2009;5 Suppl 7:770–5.
5.
go back to reference Satyanarayana U, Chakrapani U. Free radicals and antioxidants. In: Biochemistry. Kolkata-India: Books and Allied (p) ltd; 2008. p. 655–61. Satyanarayana U, Chakrapani U. Free radicals and antioxidants. In: Biochemistry. Kolkata-India: Books and Allied (p) ltd; 2008. p. 655–61.
8.
go back to reference Das BS, Turnham DI, Painack J, Das DE, Satpathy R, Base TK. Increased plasma lipid peroxidation in riboflavin deficient malaria-inflected children. Ann J Clin Nutr. 1990;51:859–63.CrossRef Das BS, Turnham DI, Painack J, Das DE, Satpathy R, Base TK. Increased plasma lipid peroxidation in riboflavin deficient malaria-inflected children. Ann J Clin Nutr. 1990;51:859–63.CrossRef
9.
go back to reference Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P. Age associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res. 2006;40:405–505.CrossRef Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P. Age associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res. 2006;40:405–505.CrossRef
10.
go back to reference Kumar KMP. Antioxidants for clinical use. Int J Diabetes Dev Ctries. 2012;32 Suppl 4:183–4.CrossRef Kumar KMP. Antioxidants for clinical use. Int J Diabetes Dev Ctries. 2012;32 Suppl 4:183–4.CrossRef
11.
go back to reference Harman D. Free radical theory of aging: An update. Ann N Y Academy Science. 2006;1067:1–12.CrossRef Harman D. Free radical theory of aging: An update. Ann N Y Academy Science. 2006;1067:1–12.CrossRef
12.
go back to reference United Nations. World Population Prospects The 2012 Revision: Key findings and advance tables Department of Economic and Social Affairs Population Division. 2013, Working Paper No. ESA/P/WP.227. United Nations. World Population Prospects The 2012 Revision: Key findings and advance tables Department of Economic and Social Affairs Population Division. 2013, Working Paper No. ESA/P/WP.227.
13.
go back to reference Deavall DG, Martin EA, Horner JM, Roberts R. Drug-Induce oxidative stress and toxicity. J Toxicol. 2012;10:1155–68. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-Induce oxidative stress and toxicity. J Toxicol. 2012;10:1155–68.
14.
15.
go back to reference Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 1999;57:104–13.PubMedCrossRef Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 1999;57:104–13.PubMedCrossRef
16.
go back to reference Hanson K, Gratton ME, Bardeen CJ. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radical Biological Medicine. 2006;11:6–11. Hanson K, Gratton ME, Bardeen CJ. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radical Biological Medicine. 2006;11:6–11.
17.
18.
go back to reference Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57 Suppl 6:1446–54.PubMedCrossRef Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57 Suppl 6:1446–54.PubMedCrossRef
19.
go back to reference Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Current Med Chem. 2009;16:94–112.CrossRef Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Current Med Chem. 2009;16:94–112.CrossRef
20.
go back to reference JNC7: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville, Md. National Heart, Lung, and Blood Institute, US Department of Health and Human Services, National Institutes of Health Publication. 2004; No. 04–5230. JNC7: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville, Md. National Heart, Lung, and Blood Institute, US Department of Health and Human Services, National Institutes of Health Publication. 2004; No. 04–5230.
21.
go back to reference ADA: American Diabetes Association. Diagnosis and classification of diabetes mellitus. Position statement. Diabetes Care. 2014;37 Suppl 1:S81–90.CrossRef ADA: American Diabetes Association. Diagnosis and classification of diabetes mellitus. Position statement. Diabetes Care. 2014;37 Suppl 1:S81–90.CrossRef
22.
go back to reference WMA: World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. 52nd WMA general assembly, Edinburgh. 2000, 17C. WMA: World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. 52nd WMA general assembly, Edinburgh. 2000, 17C.
23.
go back to reference Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Ann Biochem. 1969;27:502–22.CrossRef Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Ann Biochem. 1969;27:502–22.CrossRef
24.
go back to reference Martins JP, Dailey M, Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem. 1987;255:329–36.CrossRef Martins JP, Dailey M, Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem. 1987;255:329–36.CrossRef
25.
go back to reference Aebi HE. Catalase. In: Bergmeyer HU, editor. Method of enzymatic analysis, vol. 3. Weinheim: VCH Verlag; 1987. p. 273–8. Aebi HE. Catalase. In: Bergmeyer HU, editor. Method of enzymatic analysis, vol. 3. Weinheim: VCH Verlag; 1987. p. 273–8.
26.
go back to reference Omaye ST, Turbull TP, Sauberchich HC. Selected methods for determination of ascorbic acid in cells, tissues and fluids. Methods Enzymol. 1979;6:3–11.CrossRef Omaye ST, Turbull TP, Sauberchich HC. Selected methods for determination of ascorbic acid in cells, tissues and fluids. Methods Enzymol. 1979;6:3–11.CrossRef
28.
go back to reference Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem. 1969;6:24–7.CrossRef Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem. 1969;6:24–7.CrossRef
29.
go back to reference Perrotta G. Iron and iron-binding capacity. In: Kaplan A, editor. Clinical chemistry. St Louis, Toronto, Princeton: The C.V. Mosby Co; 1984. p. 1063–5. Perrotta G. Iron and iron-binding capacity. In: Kaplan A, editor. Clinical chemistry. St Louis, Toronto, Princeton: The C.V. Mosby Co; 1984. p. 1063–5.
30.
go back to reference Burtis A. Serum Zinc and Copper. Textbook of clinical chemistry. 3rd ed. American Association Clinical Chemists. 1999. P. 336–356. Burtis A. Serum Zinc and Copper. Textbook of clinical chemistry. 3rd ed. American Association Clinical Chemists. 1999. P. 336–356.
31.
go back to reference Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries. 2010;30:49–51.PubMedPubMedCentralCrossRef Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries. 2010;30:49–51.PubMedPubMedCentralCrossRef
32.
go back to reference Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and with-out microalbuminuria. Ann Clin Biochem. 2005;42:99–104.PubMedCrossRef Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and with-out microalbuminuria. Ann Clin Biochem. 2005;42:99–104.PubMedCrossRef
33.
go back to reference Ohtsuki T, Malasumoto M, Suzuki K, Taniguchi N, Kadanada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol. 1995;268:1418–21. Ohtsuki T, Malasumoto M, Suzuki K, Taniguchi N, Kadanada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol. 1995;268:1418–21.
34.
go back to reference Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with microvascular Complications. Open Endocrinol J. 2009;3:13–6. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with microvascular Complications. Open Endocrinol J. 2009;3:13–6.
35.
go back to reference Salem M, Kholoussi S, Κholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellenic Med. 2011;28 Suppl 1:83–8. Salem M, Kholoussi S, Κholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellenic Med. 2011;28 Suppl 1:83–8.
36.
go back to reference Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJ. Superoxide dismutase undergo proteolysis and fragmentation following oxidation modification and inactivation. J Bio Chem. 1990;15(265 Suppl 20):11919–27.CrossRef Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJ. Superoxide dismutase undergo proteolysis and fragmentation following oxidation modification and inactivation. J Bio Chem. 1990;15(265 Suppl 20):11919–27.CrossRef
37.
go back to reference Ceballos I, Delebar JM, Nicole A. Expression of transfected human Cu-Zn SOD in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochem Biophy Acta. 1998;949:58–64. Ceballos I, Delebar JM, Nicole A. Expression of transfected human Cu-Zn SOD in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochem Biophy Acta. 1998;949:58–64.
38.
go back to reference Gonenc A, Erten D, Aslan S. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006;30:376–80.PubMedCrossRef Gonenc A, Erten D, Aslan S. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006;30:376–80.PubMedCrossRef
39.
go back to reference Yeh CC, Hou MF, Tsai SM. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta. 2005;361:104–11.PubMedCrossRef Yeh CC, Hou MF, Tsai SM. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta. 2005;361:104–11.PubMedCrossRef
40.
go back to reference Kumar NL, Deepthi J, Rao YN, Deedi MK. Study of lipid profile, serum magnesium and blood glucose in hypertension. Biol Med. 2010;2 Suppl 1:6–16. Kumar NL, Deepthi J, Rao YN, Deedi MK. Study of lipid profile, serum magnesium and blood glucose in hypertension. Biol Med. 2010;2 Suppl 1:6–16.
41.
go back to reference Sozmen EY, Sozmen B, Delen Y, Onat T. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res. 2001;32:283–7.PubMedCrossRef Sozmen EY, Sozmen B, Delen Y, Onat T. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res. 2001;32:283–7.PubMedCrossRef
42.
go back to reference Farombi EO, Olowg B, Emerole GO. Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats comp. Biochem Physiol. 2000;126:217–24. Farombi EO, Olowg B, Emerole GO. Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats comp. Biochem Physiol. 2000;126:217–24.
43.
go back to reference Ruiz C, Algeria A, Barbera R, Farre R, Lagarda MJ. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol. 1998;12:91–5.PubMedCrossRef Ruiz C, Algeria A, Barbera R, Farre R, Lagarda MJ. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol. 1998;12:91–5.PubMedCrossRef
44.
go back to reference Karatas F, Halifeoglu I, Karatepe M, Konar V, Canatan H, Colak R. Evaluation of changes in the level of serum selenium, malondiadehyde and antioxidant vitamins (A, E, C) in Diabetic patients. Fusabil. 2006;20 Suppl 6:391–5. Karatas F, Halifeoglu I, Karatepe M, Konar V, Canatan H, Colak R. Evaluation of changes in the level of serum selenium, malondiadehyde and antioxidant vitamins (A, E, C) in Diabetic patients. Fusabil. 2006;20 Suppl 6:391–5.
45.
go back to reference Joshi U, Raut PD, Agrawal SK, Patra PK, Maheshwari BK, Apurb M, et al. Evaluation of serum selenium level in patients with uncomplicated diabetes mellitus, Raipur. India J Clin Diagn Res. 2011;5:70–3. Joshi U, Raut PD, Agrawal SK, Patra PK, Maheshwari BK, Apurb M, et al. Evaluation of serum selenium level in patients with uncomplicated diabetes mellitus, Raipur. India J Clin Diagn Res. 2011;5:70–3.
46.
go back to reference Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53:189S–93.PubMedCrossRef Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53:189S–93.PubMedCrossRef
47.
go back to reference Ahmad M, Khan MA, Khan AS. Oxidative stress and level of iron indices in coronary heart disease patients. J Ayub Med Coll Abbottabad. 2009;21:2–5. Ahmad M, Khan MA, Khan AS. Oxidative stress and level of iron indices in coronary heart disease patients. J Ayub Med Coll Abbottabad. 2009;21:2–5.
48.
go back to reference Vural H, Uzun K, Uz E. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. J Trace Elem Med Biol. 2000;14 Suppl 2:88–91.PubMedCrossRef Vural H, Uzun K, Uz E. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. J Trace Elem Med Biol. 2000;14 Suppl 2:88–91.PubMedCrossRef
49.
go back to reference Lin J. The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi. 1996;100 Suppl 9:672–9.PubMed Lin J. The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi. 1996;100 Suppl 9:672–9.PubMed
50.
go back to reference Mimic OJ, Simic T, Djukanovic Z. Red blood cell glutathione peroxidase and superoxide dismutase activity in different status of chronic renal failure. Clin Nephrol. 1995;44:44–8. Mimic OJ, Simic T, Djukanovic Z. Red blood cell glutathione peroxidase and superoxide dismutase activity in different status of chronic renal failure. Clin Nephrol. 1995;44:44–8.
Metadata
Title
Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients
Authors
Stanley IR Okoduwa
Ismaila A Umar
Sani Ibrahim
Fatima Bello
Nathan Habila
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2015
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-015-0164-z

Other articles of this Issue 1/2015

Journal of Diabetes & Metabolic Disorders 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.